anti-VEGFR2 antibody product blog
Tags: Antibody; VEGFR2; Polyclonal Antibody; anti-VEGFR2 antibody;
The VEGFR2 kdr (Catalog #MBS9503194) is an Antibody produced from Rabbit and is intended for research purposes only. The product is available for immediate purchase. The VEGFR2 (Phospho-Tyr1175) Antibody reacts with Human, Mouse, Rat and may cross-react with other species as described in the data sheet. MyBioSource\'s VEGFR2 can be used in a range of immunoassay formats including, but not limited to, Western Blot (WB), Immunohistochemistry (IHC), ELISA (EIA).WB: 1:500~1:1000
IHC: 1:50~1:100
ELISA: 1:10000. Researchers should empirically determine the suitability of the VEGFR2 kdr for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The VEGFR2 kdr product has the following accession number(s) (GI #11321597) (NCBI Accession #NP_002244.1) (Uniprot Accession #P35968). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Please refer to the product datasheet for known applications of a given antibody. We\'ve tested the VEGFR2 (Phospho-Tyr1175) Antibody with the following immunoassay(s):
Immunohistochemistry (IHC) (Immunohistochemistry analysis of paraffin-embedded human breast carcinoma, using VEGFR2 (Phospho-Tyr1175) Antibody. The picture on the right is blocked with the phospho peptide.)
Western Blot (WB) (Western blot analysis of lysates from HUVEC cells and NIH/3T3 cells, using VEGFR2 (Phospho-Tyr1175) Antibody. The lane on the right is blocked with the phospho peptide.)
Target Modification: Phospho
Modification Sites: H:Y1175; M:Y1173; R:Y1171. Immunogen: The antiserum was produced against synthesized peptide derived from human VEGFR2 around the phosphorylation site of Tyr1175.
Immunogen Range: 1141-1190. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing VEGFR2 are readily searchable from our website. Different antibodies against the same target such as VEGFR2 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results. Bone, Brain, Embryonic Tissue, Heart, Kidney, Liver, Lung, Muscle, Placenta, Vascular tissues are correlated with this protein. Adenocarcinoma, Atherosclerosis, Breast Neoplasms, Drug Toxicity, Heart Diseases, Inflammation, Myocardial Ischemia, Neoplasms, Neoplasms, Experimental, Neovascularization, Pathologic are some of the diseases may be linked to VEGFR2 (Phospho-Tyr1175) Antibody. VEGFR2 also interacts with the following gene(s): COL18A1, CRK, CTNNB1, FLT1, FLT4, GRB2, NRP1, SRC, VEGFA, VEGFC. The following patways have been known to be associated with this gene.